Pathologic Complete Response Predicts Long‐Term Survival Following Neoadjuvant Induction Chemotherapy and Chemo‐Radiotherapy in Stage‐III Non‐Small Cell Lung Cancer

ABSTRACT Background To analyze the association of pathologic‐complete‐response (PCR) and survival after neoadjuvant concurrent chemo‐radiotherapy, we evaluated a large cohort of patients with potentially resectable stage IIIA–IIIC non‐small cell lung cancer (NSCLC) treated with a trimodality approac...

Descripció completa

Dades bibliogràfiques

Autors principals:	Maja Guberina, Martin Metzenmacher, Christoph Pöttgen, Marcel Wiesweg, Nika Guberina, Anja Merkel‐Jens, Diana Lütke‐Brintrup, Servet Bölükbas, Wilfried E. E. Eberhardt, Georgios Stamatis, Fabian Doerr, Till Plönes, Christian Hoffmann, Gregor Zaun, Benedikt Höing, Cornelius Kürten, Emil Mladenov, George Iliakis, David Kersting, Wolfgang P. Fendler, Thomas Gauler, Marcel Opitz, Aleksandar Milosevic, Michael Forsting, Felix Nensa, Lale Umutlu, Faustina Funke, Hubertus Hautzel, Ken Herrmann, Christian Taube, Dirk Theegarten, Clemens Aigner, Martin Schuler, Martin Stuschke
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2025-11-01
Col·lecció:	Thoracic Cancer
Matèries:	induction chemo‐radiotherapy major pathological response pathologic complete response potentially resectable stage III NSCLC predictor of survival
Accés en línia:	https://doi.org/10.1111/1759-7714.70183
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!